Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization.
Corren J, Jackson DJ, Casale TB, Borish L, Rabe KF, Busse WW, Maspero JF, Jackson DJ, Daizadeh N, Altincatal A, Radwan A, Khodzhayev A, Djandji M, Jacob-Nara JA, Rowe PJ, Deniz Y.
Corren J, et al. Among authors: borish l.
J Asthma Allergy. 2023 Mar 7;16:249-260. doi: 10.2147/JAA.S385645. eCollection 2023.
J Asthma Allergy. 2023.
PMID: 36915284
Free PMC article.